NMSC Measure Testing Specifications
Measure Title
Type of
Measure
Denominator
Numerator
Use of Mohs Surgery for Superficial
Basal Cell Carcinomas on the
Trunk
Process
All pathologically-proven primary superficial
basal cell carcinoma (BCC) lesions on the trunk
(chest, back, abdomen) on immune-competent
patients treated by the provider within the
reporting period.
Number of pathologically-proven primary superficial
BCC’s treated by the provider utilizing Mohs surgery.
Use Of Mohs Surgery For
Squamous Cell Carcinoma In Situ
And Keratoacanthoma Type Squamous Cell Carcinoma On The
Trunk that are 1 cm or smaller
Process
All pathologically-proven primary SCCis or
SCC-KA lesions on the trunk (chest, back,
abdomen) that are 1 cm or smaller in
immunocompetent patients treated by the
provider within the reporting period.
Number of pathologically-proven primary SCCis or SCCKA lesions on the trunk (chest, back, abdomen) that are 1
cm or smaller in immunocompetent patients treated by the
provider utilizing Mohs surgery.
Biopsy Reporting Time –
Pathologist
Process
critical to
outcomes
All pathology reports generated by the
Pathologist/Dermatopathologist consistent with
cutaneous basal cell carcinoma or squamous cell
carcinoma (to include in situ disease).
Number of final pathology reports diagnosing cutaneous
basal cell carcinoma or squamous cell carcinoma (to
include in situ disease) sent from the Pathologist/
Dermatopathologist to the biopsying clinician for review
within 5 business days from the time when the tissue
specimen was received by the pathologist.
Biopsy Reporting Time – Clinician
Process
critical to
outcomes
All cutaneous biopsies by the clinician consistent
with cutaneous basal or squamous cell carcinoma
(including in situ disease).
Number of cutaneous biopsies by the clinician consistent
with basal cell carcinoma or squamous cell carcinoma (to
include in situ disease) for which the patient was notified
of their final biopsy pathology findings within 15 business
days from the time when the biopsy was performed.
Distinct dates of service resulting in an eligible patient
procedure should be reported separately.
Biopsy Clinical History Anatomic
Location Accuracy
Intermediate
Outcome
All cutaneous biopsies by the clinician consistent
with cutaneous basal or squamous cell carcinoma
(including in situ disease).
Number of cutaneous biopsies by the clinician for which
the clinical site listed on the clinical history portion of the
pathology report is NOT consistent with the clinical
information in the clinician’s biopsy tracking system or
with the actual biopsy site on the patient.
American Academy of Dermatology
June 19, 2015